Jekat F W, Sourgens H, Kemper F H
Institut für Pharmakologie und Toxikologie, Westfälische Wilhelms-Universität Münster, Fed. Rep. of Germany.
Arzneimittelforschung. 1993 Oct;43(10):1064-8.
3,5-Dimethyl-3'-isopropyl-L-thyronine (DIMIT, CAS 26384-44-1), a non-halogenated, artificial analogue of the thyroid hormone T3, was administered once daily by intragastric gavage to pregnant Wistar rats on days 17-20 of gestation to elucidate the effects of DIMIT on maternal and foetal thyroid state and gestational outcome under the influence of low iodine or iodine excess nutrition. Doses of 20 micrograms.kg-1.d-1 and 150 micrograms.kg-1.d-1 DIMIT were applied. Throughout pregnancy the animals were kept on low iodine diet and either on iodine free drinking water or iodine excess. There was no statistically significant effect on maternal body weight, weight of living foetus, the rate of intra-uterine death before day 16 of gestation, water and food consumption, and no hint of maternal thyrotoxicosis. The vital off-spring did not reveal any signs of gross malformation. DIMIT decreased serum TSH both in dams and foetus, and diminished the TSH stock of the pituitary gland of the dams. T3-levels were also lowered in maternal serum by DIMIT. These DIMIT induced effects were observed irrespective of iodine deficiency or excess. There was no difference in foetal mortality before onset of DIMIT-treatment, but the gestational death rate increased in a dose-related manner by the administration of DIMIT. This serious adverse effect became apparent at a DIMIT-dose that is not sufficient for a complete compensation of foetal hypothyroidism in utero. The higher prenatal mortality was accompanied by a decreased placental weight, but not by a reduced body weight of surviving foetus.
3,5 - 二甲基 - 3'-异丙基 - L - 甲状腺原氨酸(DIMIT,化学物质登记号26384 - 44 - 1)是一种非卤化的甲状腺激素T3人工类似物,在妊娠第17至20天,通过胃内灌胃法每天给怀孕的Wistar大鼠给药一次,以阐明在低碘或碘过量营养影响下DIMIT对母体和胎儿甲状腺状态及妊娠结局的影响。应用了20微克·千克⁻¹·天⁻¹和150微克·千克⁻¹·天⁻¹的DIMIT剂量。在整个孕期,动物被给予低碘饮食,并饮用无碘水或高碘水。对母体体重、存活胎儿体重、妊娠第16天前的宫内死亡率、水和食物消耗量均无统计学显著影响,也没有母体甲状腺毒症的迹象。存活后代未显示任何明显畸形的迹象。DIMIT降低了母鼠和胎儿的血清促甲状腺激素(TSH)水平,并减少了母鼠垂体中的TSH储备。DIMIT还降低了母体血清中的T3水平。无论碘缺乏或过量,均观察到这些DIMIT诱导的效应。在开始DIMIT治疗前,胎儿死亡率没有差异,但给予DIMIT后,妊娠死亡率呈剂量相关增加。这种严重的不良反应在一个不足以完全补偿子宫内胎儿甲状腺功能减退的DIMIT剂量下就很明显。较高的产前死亡率伴随着胎盘重量的降低,但存活胎儿的体重并未减轻。